Nicola Kegel, CEO of Nanogami, develops DNA origami nanotech for diagnostics and cancer treatment. With a biology and computer science background, she has a decade of entrepreneurial experience and served as a business consultant at McKinsey & Company. She's also an Innovation Manager for Germany's federal agency for disruptive innovation.